Tobolowsky, Farrell ANsubuga, FredGilani, ZuneraKisakye, AnnetNdagije, HelenKyabayinze, DanielGidudu, Jane F2024-04-042024-04-042024-04Tobolowsky, Farrell A., Fred Nsubuga, Zunera Gilani, et al. 'Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022', Emerging Infectious Diseases, vol. 30/no. 4, (2024), pp. 775-778.ISSN 1080-6040EISSN 1080-6059https://nru.uncst.go.ug/handle/123456789/9470Abstract Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.envaccine-related paralysis; novel oral poliovirus vaccine type 2; Safety Evaluation; Immunization; UgandaArticle